These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36859467)

  • 21. Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy.
    Borges K; Kaul N; Germaine J; Kwan P; O'Brien TJ
    Epilepsia Open; 2019 Mar; 4(1):153-163. PubMed ID: 30868125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    Yuan X; Wang L; Tandon N; Sun H; Tian J; Du H; Pascual JM; Guo L
    J Alzheimers Dis; 2020; 78(1):425-437. PubMed ID: 33016909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic changes in dairy cows with ketonemia in response to feed restriction and dietary 1,3-butanediol.
    Drackley JK; Richard MJ; Beitz DC; Young JW
    J Dairy Sci; 1992 Jun; 75(6):1622-34. PubMed ID: 1500562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
    Roe CR; Brunengraber H
    Mol Genet Metab; 2015 Dec; 116(4):260-8. PubMed ID: 26547562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triheptanoin Alleviates Ventricular Hypertrophy and Improves Myocardial Glucose Oxidation in Rats With Pressure Overload.
    Nguyen TD; Shingu Y; Amorim PA; Schwarzer M; Doenst T
    J Card Fail; 2015 Nov; 21(11):906-15. PubMed ID: 26209001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile.
    Gu L; Zhang GF; Kombu RS; Allen F; Kutz G; Brewer WU; Roe CR; Brunengraber H
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E362-71. PubMed ID: 19903863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders.
    Zöggeler T; Stock K; Jörg-Streller M; Spenger J; Konstantopoulou V; Hufgard-Leitner M; Scholl-Bürgi S; Karall D
    Orphanet J Rare Dis; 2021 Jan; 16(1):28. PubMed ID: 33446227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Glucose Transport Modulators In Vitro and Method for Their Deep Learning Neural Network Behavioral Evaluation in Glucose Transporter 1-Deficient Mice.
    Kathote G; Ma Q; Angulo G; Chen H; Jakkamsetti V; Dobariya A; Good LB; Posner B; Park JY; Pascual JM
    J Pharmacol Exp Ther; 2023 Mar; 384(3):393-405. PubMed ID: 36635085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional ketosis delays the onset of isoflurane induced anesthesia.
    Ari C; Kovács Z; Murdun C; Koutnik AP; Goldhagen CR; Rogers C; Diamond D; D'Agostino DP
    BMC Anesthesiol; 2018 Jul; 18(1):85. PubMed ID: 30021521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
    Gillingham MB; Heitner SB; Martin J; Rose S; Goldstein A; El-Gharbawy AH; Deward S; Lasarev MR; Pollaro J; DeLany JP; Burchill LJ; Goodpaster B; Shoemaker J; Matern D; Harding CO; Vockley J
    J Inherit Metab Dis; 2017 Nov; 40(6):831-843. PubMed ID: 28871440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.
    Willis S; Stoll J; Sweetman L; Borges K
    Neurobiol Dis; 2010 Dec; 40(3):565-72. PubMed ID: 20691264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
    Winczewska-Wiktor A; Hoffman-Zacharska D; Starczewska M; Kaczmarek I; Badura-Stronka M; Steinborn B
    Epilepsy Behav; 2020 May; 106():107036. PubMed ID: 32247176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.
    Vockley J; Burton B; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman K; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Cataldo J
    J Inherit Metab Dis; 2021 Jan; 44(1):253-263. PubMed ID: 32885845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
    Norris MK; Scott AI; Sullivan S; Chang IJ; Lam C; Sun A; Hahn S; Thies JM; Gunnarson M; McKean KN; Merritt JL
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):230-238. PubMed ID: 33085788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red blood cells as glucose carriers to the human brain: Modulation of cerebral activity by erythrocyte exchange transfusion in Glut1 deficiency (G1D).
    Wang RC; Lee EE; De Simone N; Kathote G; Primeaux S; Avila A; Yu DM; Johnson M; Good LB; Jakkamsetti V; Sarode R; Holland AA; Pascual JM
    J Cereb Blood Flow Metab; 2023 Mar; 43(3):357-368. PubMed ID: 36523131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a LC-MS/MS method for quantitation of 3-hydroxypentanoic acid and 3-oxopentanoic acid in human plasma and its application to a clinical study of glucose transporter type I deficiency (G1D) syndrome.
    Kallem RR; Primeaux S; Avila A; Pascual JM; Putnam WC
    J Pharm Biomed Anal; 2021 Oct; 205():114335. PubMed ID: 34482182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy.
    Kim TH; Borges K; Petrou S; Reid CA
    Epilepsy Res; 2013 Jan; 103(1):101-5. PubMed ID: 23196212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin.
    Breen C; White FJ; Scott CA; Heptinstall L; Walter JH; Jones SA; Morris AA
    Eur J Pediatr; 2014 Mar; 173(3):361-6. PubMed ID: 24114256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triheptanoin in acute mouse seizure models.
    Thomas NK; Willis S; Sweetman L; Borges K
    Epilepsy Res; 2012 May; 99(3):312-7. PubMed ID: 22260920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.